Related Experiment Videos
A microplate system for ABO and Rh(D) blood grouping
1National Reference Laboratory, Canadian Red Cross Society, Ottawa, Ontario, Canada.
Transfusion
|May 1, 1993
Summary
This study describes a new microplate system for blood group ABO and Rh(D) testing. The automated system accurately determined blood types for 97.3% of 10,042 donor samples, improving efficiency in blood banking.
Area of Science:
- Transfusion Medicine
- Clinical Laboratory Science
Background:
- Automated blood grouping systems are crucial for efficient and accurate blood type determination in transfusion medicine.
- Manual methods for ABO and Rh(D) grouping can be time-consuming and prone to errors.
- Evaluating new automated systems is essential for improving laboratory workflows and patient safety.
Purpose of the Study:
- To describe and evaluate the performance of a novel microplate system for ABO and Rh(D) blood group determinations.
- To compare the accuracy and efficiency of the microplate system against established automated and manual blood grouping techniques.
Main Methods:
- A microplate system integrating a Kemble Kemtek 1000SP liquid handler, Anthos 2001 microplate reader, and Sanguin Forma software was utilized.
- The system was evaluated using 10,042 routine blood donor samples, with parallel testing against a Technicon AutoAnalyzer.
- Manual techniques were employed for ABO reverse groupings, discrepancy resolution, and confirmation of D-negative results via indirect antiglobulin testing.
Main Results:
- The microplate system achieved a 97.3% correct grouping rate for ABO and Rh(D) across 10,042 samples.
- 266 samples (2.6%) were flagged with 'no type determined' (124 for ABO, 142 for Rh).
- An additional 30 weak D samples, missed by both automated systems, were identified using manual indirect antiglobulin tests.
Conclusions:
- The described microplate system offers a flexible, maintainable, and operable solution for ABO and Rh(D) blood grouping.
- The system demonstrates high accuracy and potential for improving efficiency in blood donor screening.
- Complementary manual testing remains important for resolving discrepancies and detecting weak D variants.